Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane
Biogen Inc (NASDAQ: BIIB) and Xbrane Biopharma AB have
UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights
Belgian-based UCB SA (OTC: UCBJF) has agreed to buy Zogenix Inc (NASDAQ: ZGNX), a U.S.
UCB Gets EU Approval For Bimekizumab In Psoriasis
The European Commission has cleared UCB’s (OTC:UCBJF) Bimzelx (bimekizumab) for moderate to severe plaque psoriasis in adults. UCB’s confidence lies in…